N
AMED

Nuveen’s Amedisys AMED Stock Holding History

Nuveen’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-63,266
Closed -$6.22M – 3257
2025
Q2 		$6.22M Sell
63,266
-8,365
-12% -$791K ﹤0.01% 1773
2025
Q1 		$6.64M Buy
71,631
+13,148
+22% +$1.21M ﹤0.01% 1776
2024
Q4 		$5.31M Sell
58,483
-13,223
-18% -$1.21M ﹤0.01% 1955
2024
Q3 		$6.92M Buy
71,706
+9,807
+16% +$957K ﹤0.01% 1826
2024
Q2 		$5.68M Sell
61,899
-6,558
-10% -$609K ﹤0.01% 1883
2024
Q1 		$6.31M Buy
68,457
+987
+1% +$92.5K ﹤0.01% 1857
2023
Q4 		$6.41M Sell
67,470
-11,927
-15% -$1.11M ﹤0.01% 1838
2023
Q3 		$7.42M Buy
79,397
+5,351
+7% +$494K ﹤0.01% 1652
2023
Q2 		$6.77M Sell
74,046
-319
-0.4% -$26.2K ﹤0.01% 1751
2023
Q1 		$5.47M Sell
74,365
-818
-1% -$70.8K ﹤0.01% 1840
2022
Q4 		$6.28M Sell
75,183
-2,357
-3% -$213K ﹤0.01% 1784
2022
Q3 		$7.5M Sell
77,540
-2,636
-3% -$314K ﹤0.01% 1664
2022
Q2 		$8.43M Sell
80,176
-4,408
-5% -$563K ﹤0.01% 1624
2022
Q1 		$13.6M Buy
84,584
+107
+0.1% +$16K ﹤0.01% 1446
2021
Q4 		$13.7M Sell
84,477
-17,496
-17% -$2.81M ﹤0.01% 1494
2021
Q3 		$15.2M Sell
101,973
-47,277
-32% -$9.83M ﹤0.01% 1470
2021
Q2 		$36.6M Sell
149,250
-22,460
-13% -$5.89M 0.01% 928
2021
Q1 		$45.5M Sell
171,710
-8,363
-5% -$2.36M 0.01% 775
2020
Q4 		$52.8M Buy
180,073
+5,987
+3% +$1.54M 0.02% 671
2020
Q3 		$41.2M Buy
174,086
+77,628
+80% +$17.6M 0.02% 663
2020
Q2 		$19.2M Sell
96,458
-117,563
-55% -$21.9M 0.01% 1070
2020
Q1 		$39.3M Buy
214,021
+22,535
+12% +$4.01M 0.02% 579
2019
Q4 		$32M Sell
191,486
-63,634
-25% -$9.46M 0.01% 908
2019
Q3 		$33.4M Sell
255,120
-5,988
-2% -$780K 0.01% 865
2019
Q2 		$31.7M Buy
261,108
+249,280
+2,108% +$29.6M 0.01% 915
2019
Q1 		$1.46M Buy
11,828
+1,110
+10% +$139K 0.01% 681
2018
Q4 		$1.25M Sell
10,718
-2,481
-19% -$292K 0.01% 679
2018
Q3 		$1.65M Sell
13,199
-11,636
-47% -$1.28M 0.01% 674
2018
Q2 		$2.12M Sell
24,835
-19,428
-44% -$1.43M 0.01% 609
2018
Q1 		$2.67M Buy
+44,263
New +$2.52M 0.02% 571
2017
Q3 		– Sell
-19,661
Closed -$1.24M – 1098
2017
Q2 		$1.24M Sell
19,661
-5,276
-21% -$307K 0.01% 705
2017
Q1 		$1.27M Sell
24,937
-6,970
-22% -$332K 0.01% 875
2016
Q4 		$1.36M Buy
31,907
+5,827
+22% +$248K 0.01% 1039
2016
Q3 		$1.24M Buy
26,080
+3,399
+15% +$170K 0.01% 1005
2016
Q2 		$1.15M Sell
22,681
-22,701
-50% -$1.15M 0.01% 982
2016
Q1 		$2.19K Buy
45,382
+14,334
+46% +$553K 0.01% 706
2015
Q4 		$1.22K Sell
31,048
-2,747
-8% -$110K 0.01% 970
2015
Q3 		$1.28K Buy
+33,795
New +$1.43M 0.01% 962

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Nuveen's AMED Position: Q3 2025 in Review

Nuveen sold out of Amedisys (AMED) in Q3 2025, closing a stake of 63,266 shares — an estimated $6.22M sold.

Nuveen first reported a position in AMED in Q3 2015 and held it in 38 quarters. The position peaked at $52.8M in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Nuveen reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Nuveen sold 63,266 Amedisys shares in Q3 2025, an estimated $6.22M.
  • Nuveen first reported a position in Amedisys in Q3 2015 and held it in 38 quarters.
  • Nuveen's Amedisys position peaked at $52.8M in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Nuveen's 13F filing for Q3 2025, filed 12 Nov 2025.